Elon H.C. van Dijk
Elon H.C. van Dijk
Leiden University Medical Center
Geverifieerd e-mailadres voor lumc.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Central serous chorioretinopathy: towards an evidence-based treatment guideline
TJ Van Rijssen, EH Van Dijk, S Yzer, K Ohno-Matsui, JEE Keunen, ...
Progress in retinal and eye research 73, 100770, 2019
782019
Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial
EHC van Dijk, S Fauser, MB Breukink, R Blanco-Garavito, ...
Ophthalmology 125 (10), 1547-1555, 2018
762018
Serous retinopathy associated with mitogen-activated protein kinase kinase inhibition (binimetinib) for metastatic cutaneous and uveal melanoma
EHC Van Dijk, CML Van Herpen, M Marinkovic, JBAG Haanen, ...
Ophthalmology 122 (9), 1907-1916, 2015
422015
Association of a haplotype in the NR3C2 gene, encoding the mineralocorticoid receptor, with chronic central serous chorioretinopathy
EHC van Dijk, RL Schellevis, MGJM van Bergen, MB Breukink, L Altay, ...
JAMA ophthalmology 135 (5), 446-451, 2017
382017
Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial …
MB Breukink, SM Downes, G Querques, EHC van Dijk, AI den Hollander, ...
Trials 16 (1), 1-17, 2015
332015
Human iPSC-derived retinas recapitulate the fetal CRB1 CRB2 complex formation and demonstrate that photoreceptors and Müller glia are targets of AAV5
PM Quinn, TM Buck, AA Mulder, C Ohonin, CH Alves, RM Vos, M Bialecka, ...
Stem Cell Reports 12 (5), 906-919, 2019
252019
Loss of MAPK pathway activation in post-mitotic retinal cells as mechanism in MEK inhibition-related retinopathy in cancer patients
EHC van Dijk, DEM Duits, M Versluis, GPM Luyten, AAB Bergen, ...
Medicine 95 (18), 2016
232016
Role of the complement system in chronic central serous chorioretinopathy: a genome-wide association study
RL Schellevis, EHC van Dijk, MB Breukink, L Altay, B Bakker, ...
JAMA ophthalmology 136 (10), 1128-1136, 2018
222018
Behçet’s disease, hospital-based prevalence and manifestations in the Rotterdam area
JH Kappen, EHC van Dijk, M Baak-Dijkstra, PL van Daele, WK Lam-Tse, ...
Neth J Med 73 (10), 471-7, 2015
222015
Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser: PLACE Trial Report No. 3
TJ Van Rijssen, EHC Van Dijk, P Scholz, MB Breukink, R Blanco-Garavito, ...
American journal of ophthalmology 205, 1-10, 2019
212019
Central serous chorioretinopathy in primary hyperaldosteronism
EHC Van Dijk, MF Nijhoff, EK de Jong, OC Meijer, APJ de Vries, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 254 (10), 2033-2042, 2016
212016
Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
D Mohabati, TJ van Rijssen, EHC van Dijk, GPM Luyten, TO Missotten, ...
Clinical Ophthalmology (Auckland, NZ) 12, 1061, 2018
192018
Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome
EHC van Dijk, G Dijkman, NR Biermasz, FM van Haalen, AM Pereira, ...
European journal of ophthalmology 26 (5), 442-448, 2016
172016
Reshaping ophthalmology training after COVID-19 pandemic
M Ferrara, V Romano, DH Steel, R Gupta, C Iovino, EHC van Dijk, ...
Eye 34 (11), 2089-2097, 2020
162020
cushing’s syndrome and hypothalamic–Pituitary–adrenal axis hyperactivity in chronic central serous chorioretinopathy
FM Van Haalen, EHC van Dijk, OM Dekkers, MB Bizino, G Dijkman, ...
Frontiers in endocrinology 9, 39, 2018
162018
Discrepancy in current central serous chorioretinopathy classification
SR Singh, A Matet, EHC Van Dijk, A Daruich, S Fauser, S Yzer, E Peiretti, ...
British Journal of Ophthalmology 103 (6), 737-742, 2019
152019
Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose …
TJ van Rijssen, D Mohabati, G Dijkman, T Theelen, EK de Jong, ...
PloS one 13 (8), e0202549, 2018
152018
Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
TJ van Rijssen, EHC van Dijk, G Dijkman, CJF Boon
Graefe's Archive for Clinical and Experimental Ophthalmology 256 (8), 1395-1402, 2018
152018
Efficacy of photodynamic therapy in steroid‐associated chronic central serous chorioretinopathy: a case–control study
MB Breukink, D Mohabati, EHC van Dijk, AI den Hollander, EK de Jong, ...
Acta ophthalmologica 94 (6), 565-572, 2016
142016
Short-Term findings on optical coherence tomography and Microperimetry in chronic central serous Chorioretinopathy patients treated with half-dose photodynamic therapy
EHC van Dijk, G Dijkman, T Theelen, CB Hoyng, CJF Boon
Retinal Cases and Brief Reports 12 (4), 266-271, 2018
112018
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20